home / stock / aneb / aneb news

ANEB News and Press, Anebulo Pharmaceuticals Inc. From 09/26/22

Stock Information
Company Name: Anebulo Pharmaceuticals Inc.
Stock Symbol: ANEB
Market: NASDAQ
Website: anebulo.com
Menu
ANEB ANEB Quote ANEB Short ANEB News ANEB Articles ANEB Message Board
Get ANEB Alerts

News, Short Squeeze, Breakout and More Instantly...
ANEB - Anebulo Pharmaceuticals to launch private investment in public equity financing

Anebulo Pharmaceuticals ( NASDAQ: ANEB ) will sell an aggregate of 2.3M shares and accompanying warrants to purchase up to 2.3M shares to certain institutional accredited investors through a private investment in public equity financing at $2.935 per share and accompanyin...
ANEB - Anebulo Pharmaceuticals Announces Positive Interim Data for ANEB-001 from Part B of its Phase 2 Clinical Trial for Acute Cannabinoid Intoxication

Lower doses of ANEB-001 reduced the negative effects of higher doses of THC Currently exploring delayed dosing to better understand real-world conditions Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing n...

ANEB - Anebulo Pharmaceuticals Announces $6.6 Million Private Placement Financing

Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication (ACI) and substance addiction (the “Company” or “Anebulo”), today announced that i...

ANEB - Anebulo Pharmaceuticals to Webcast R&D Day on September 26, 2022

Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication (ACI) and substance abuse disorder (the “Company” or “Anebulo”), will host its ina...
ANEB - Anebulo Pharmaceuticals GAAP EPS of -$0.10 misses by $0.03

Anebulo Pharmaceuticals press release ( NASDAQ: ANEB ): Q4 GAAP EPS of -$0.10 misses by $0.03 . Cash balance was $14.5 million as of June 30, 2022. For further details see: Anebulo Pharmaceuticals GAAP EPS of -$0.10 misses by $0.03

ANEB - Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Highlights Recent Business Progress

Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication and substance abuse (the “Company” or “Anebulo”), today announced financial result...

ANEB - Anebulo Pharmaceuticals to Host Inaugural R&D Day in New York City on Monday, September 26

Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication (ACI) and substance abuse disorder (the “Company” or “Anebulo”), will host its ina...
ANEB - Sidoti's August Micro-Cap Virtual Conference

Presentation Times and Weblinks Released for Over 50 Presenting Companies Wednesday and Thursday, August 17-18, 2022 NEW YORK, NY / ACCESSWIRE / August 16, 2022 / Sidoti & Company, LLC has released the presentation schedule and weblinks for its two-day August Micro-Cap Confer...

ANEB - KOPN, BPT and CLVR among mid-day movers-

Gainers: Canoo ( GOEV ) +28% . Kaspien Holdings ( KSPN ) +18% . Clever Leaves Holdings ( CLVR ) +20% . Yatsen Holding ( YSG ) +17% . Lucira Health ( LHDX ) +17% . Revelation Biosciences ( REVB ) +16% . Kopin Corpo...

ANEB - Biomerica, Clene top healthcare gainers; ContraFect, Novavax lead losers' pack

Gainers: Biomerica ( BMRA ) +23% . Clene ( CLNN ) +22% . Gossamer Bio ( GOSS ) +11% . Revelation Biosciences ( REVB ) +10% . Nutriband ( NTRB ) +7% . Losers: ContraFect ( CFRX ) -81% . Novavax ( NVAX ) -1...
Previous 10 Next 10